Current treatment options in neuropathic pain

Current Opinion in Investigational Drugs

Volumn 3, Issue 3, 2002, Pages 441-448

  Hempenstall, Kathleen ^a   Rice, Andrew S C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anesthetics; Antiepileptics; Neuropathic pain; Opioids; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CANNABINOID; CAPSAICIN; DEXTROMETHORPHAN; DIAZEPAM; FENTANYL; GABAPENTIN; KETAMINE; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MAPROTILINE; MEMANTINE; MEXILETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NERVE GROWTH FACTOR ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ADRENERGIC SYSTEM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HUMAN; INHIBITION KINETICS; MENTAL DISEASE; NERVE SPROUTING; NEURALGIA; NEUROLOGIC DISEASE; NOCICEPTIVE STIMULATION; OUTCOMES RESEARCH; PAIN CLINIC; PATHOPHYSIOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIZATION; SENSORY NERVE; SPINAL CORD FUNCTION; SPINAL CORD STIMULATION; SYMPTOM;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM; HUMANS; NERVE GROWTH FACTORS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME;

EID: 0036228360     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Classification of chronic pain
2. Symptomatic treatment of painful neuropathy
3. The management of post-herpetic neuralgia
4. Neuropathic pain syndromes and their management
5. Neuropathic pain of peripheral origin: Advances in pharmacological treatment
6. Painful neuropathies
7. Mechanisms of neuropathic pain
8. Drug treatment of neuropathic pain
9. Treatment options in postherpetic neuralgia
10. Neuropathic pain: Aetiology, symptoms, mechanism and management
11. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
12. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation
13. Treatment of postherpetic neuralgia. An update
14. A systematic review of antidepressants in neuropathic pain
15. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
16. Anticonvulsant drugs for management of pain: A systematic review
17. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review
18. The number needed to treat: A clinically useful measure of treatment effect
19. Efficacy and safety of NSAIDS in the therapy of diabetic neuropathy
20. Are opioids effective in relieving neuropathic pain?
21. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled single dose studies
22. Efficacy of oxycodone in neuropathic pain. A randomised trial in postherpetic neuralgia
23. Randomised double blind active placebo controlled cross over trial of intravenous fentanyl in neuropathic pain
24. Double blind randomised trial of tramadol for the treatment of the pain of diabetic neuropathy
25. Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double blind, controlled trial
26. Treatments for postherpetic neuralgia - A systematic review of randomised controlled trials
27. Acupuncture and amitriptyline for pain due to HIV related peripheral neuropathy
28. A randomised trial of amitriptyline and mexiletine for painful neuropathy in HIV infection
29. Nortriptyline versus amitriptyline in postherpetic neuralgia. A randomised trial
30. Amitriptyline versus maprolitine in postherpetic neuralgia: A randomised, double blind cross over trial
31. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
32. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
33. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
34. 2δ subunit of a calcium channel
35. Gabapentin inhibits calcium currents in isolated rat brain neurons
36. Gabapentin for the treatment of postherpetic neuralgia
37. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus
38. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study
39. Lamotrigine in refractory trigeminal neuralgia: Results of a double blind placebo controlled cross over study
40. A placebo controlled trial of lamotrigine for painful HIV associated neuropathy
41. 200mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double blind, placebo controlled trial
42. A randomised double blind study comparing the efficacy of gabapentin with amitriptyline in diabetic peripheral neuropathy pain
43. Gabapentin versus amitriptyline in painful diabetic neuropathy: An open label pilot study
44. Systemic lidocaine silences ectopic neuroma and dorsal root ganglion discharge without blocking nerve conduction
45. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy
46. Lidocaine patch: Double blind controlled study of a new treatment method for postherpetic neuralgia
47. Topical lidocaine gel relieves postherpetic neuralgia
48. A double blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy
49. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain and allodynia: A double blind comparison to alfentanil and placebo
50. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride
51. The effect of ketamine on phantom limb pain: A central neuropathic disorder maintained by peripheral input
52. Memantine (a N-methyl D-aspartate receptor antagonist) in the treatment of neuropathic pain following amputation or surgery - A randomised, double blinded, cross over study
53. The NMDA (N-methyl D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: A double blind, placebo controlled study
54. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
55. Dextromethorphan for the treatment of neuropathic pain: A double blind randomised controlled cross over trial with integral n-of-1 design
56. Baclofen in the treatment of trigeminal neuralgia: Double blind study and long term follow-up
57. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia
58. Trophic factors and pain
59. NGF but not NT-3 or BDNF prevents the A fiber sprouting into lamina II of the spinal cord that occurs following axotomy
60. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection